Study Maps Extensive Disease Links Beyond Childhood Eczema Medscape Source link
Lebrikizumab plus TCS shows sustained disease control in refractory atopic dermatitis Hospital Healthcare Europe Source link
Kymera’s STAT6 Degrader for Inflammatory Disease Shows Early Success in Phase I Genetic Engineering and Biotechnology News Source link
Prolonged Delgocitinib Use and Disease Control in Hand Eczema Physician’s Weekly Source link